Lodi Valley News.com

Complete News World

Health opens new age groups for vaccinating diabetics, physical educators, education workers and public transportation

Rosanna Nunes On May 2, 2021

On Monday, May 3, the Kurumba Ministry of Health opens the COVID-19 vaccination for diabetics 18 years of age or older, provided they submit a medical report; A body educator over 30 years old; Education workers over the age of 40 and public transport workers in urban areas over the age of 18. These last three groups must provide a document proving the job.

There are two driving points: in Polisportivo da Porto Carrero and in Piazza CEU, in the Jardim dos Estados district, which will operate from 7:30 in the morning until 4:00 in the evening. Who does not have transportation can find the fixed point which also works in both locations.

Who will receive the first dose should register on the website http://vacina.corumba.ms.gov.br/coronavirus/. The SUS card number is required. The municipality confirms that it is following the national vaccination plan, and that the vaccination of priority groups is done gradually. As new doses arrive, it will be open to other ages and other comorbidities.

Koronavac

As of the second Sunday in May, Kurumba had received 30,147 doses of vaccines and were applied 28.281, According to the Municipal Health Scale. The application of the second dose of the Coronavac vaccine is still pending in the city. People who are in the vaccination period will only be called when the doses arrive, according to the Municipal Health Secretariat.

The Ministry of Health advises residents to take the second dose of the covid-19 vaccine even if the application is done after the deadline recommended by the laboratory, and stresses the importance of completing the vaccination schedule to ensure adequate protection against the disease. Recommendations are in Technical Standard No. 457/2021-CGPNI / DEIDT / SVS / MS published by the National Immunization Program (PNI).

See also  GDF and Sesc provide venues for mammography and cytopathological testing in a series of actions against cancer